[Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats].
Haloperidol (1 mg/kg) was shown to increase significantly the dopamine (DA) turnover in n. accumbens and striatum and to a lesser degree in frontal cortex and hypothalamus of the rat brain; to decrease the noradrenaline content in hypothalamus. Sulpiride (50 mg/kg) slightly increased DA turnover in striatum and hypothalamus and lowered the serotonin (5-HT) content in frontal cortex. Carbidine (25 mg/kg) was found to increase DA turnover in frontal cortex, striatum and hypothalamus to a greater degree than haloperidol; 5-HT turnover was increased in all the cerebral regions. The results obtained indicated that the atypical neuroleptic drug carbidine exerts the predominant effect on the frontal cortex, the serotoninergic component being clearly pronounced.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001679:Biogenic Amines / Q000032:analysis / Q000378:metabolism*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002243:Carbolines / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013469:Sulpiride / Q000494:pharmacology*
D014150:Antipsychotic Agents; D001679:Biogenic Amines; D002243:Carbolines; D013469:Sulpiride; D006220:Haloperidol; C100106:dicarbine
Vliianie karbidina, sul'pirida i galoperidola na soderzhanie monoaminov i ikh metabolitov v strukturakh golovnogo mozga krys.